Tumours of Haematopoietic and Lymphoid Tissues
Jump to navigation
Jump to search
Myeloproliferative Neoplasms (MPN) (Overview Page Link)
- HAEM5:Chronic myeloid leukaemia
- HAEM5:Chronic neutrophilic leukaemia
- HAEM5:Polycythaemia vera
- HAEM5:Primary myelofibrosis
- HAEM5:Essential thrombocythaemia
- HAEM5:Chronic eosinophilic leukaemia
- HAEM5:Myeloproliferative neoplasm, NOS
Mastocytosis (Overview Page Link)
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 (Overview Page Link)
- HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement
- HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement
- HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement
- HAEM5:Myeloid/lymphoid neoplasm with JAK2 rearrangement
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) (Overview Page Link)
- HAEM5:Chronic myelomonocytic leukaemia
- HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia
- HAEM5:Juvenile myelomonocytic leukaemia
- MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
- MDS/MPN, Unclassifiable
Myelodysplastic Syndromes (MDS) (Overview Page Link)
- MDS with Single Lineage Dysplasia
- MDS with Ring Sideroblasts (MDS-RS)
- MDS with Ring Sideroblasts and Multilineage Dysplasia
- MDS with Multilineage Dysplasia
- MDS with Excess Blasts
- MDS with Isolated del(5q)
- MDS, Unclassifiable
- HAEM4:Refractory Cytopenia of Childhood
Myeloid Neoplasms with Germline Predisposition (Overview Page Link)
- HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation
- HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation
- HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation
- HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation
- HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation
- HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms (Overview Page Link)
- AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 - AML with t(6;9)(p23;q34.1); DEK-NUP214 - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 - AML with BCR-ABL1 - AML with Mutated NPM1 - AML with Biallelic Mutations of CEBPA - AML with Mutated RUNX1
- AML with Minimal Differentiation - AML without Maturation - AML with Maturation - HAEM5:Acute myelomonocytic leukaemia - HAEM5:Acute monocytic leukaemia - HAEM5:Acute erythroid leukaemia - HAEM5:Acute megakaryoblastic leukaemia - HAEM5:Acute basophilic leukaemia - HAEM4:Acute Panmyelosis with Myelofibrosis
- HAEM5:Myeloid proliferations associated with Down syndrome - HAEM5:Myeloid proliferations associated with Down syndrome
Blastic Plasmacytoid Dendritic Cell Neoplasm (Overview Page Link)
Acute Leukemias of Ambiguous Lineage (MPAL) (Overview Page Link)
- HAEM5:Acute undifferentiated leukaemia - HAEM5:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion - HAEM5:Mixed-phenotype acute leukaemia with KMT2A rearrangement - HAEM5:Mixed-phenotype acute leukaemia, B/myeloid - HAEM5:Mixed-phenotype acute leukaemia, T/myeloid - HAEM5:Mixed-phenotype acute leukaemia, rare types - HAEM4:Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)
Precursor Lymphoid Neoplasms (B-ALL, T-ALL) (Overview Page Link)
- B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1 - B-ALL with t(v;11q23.3); KMT2A-Rearranged - B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1 - B-ALL with Hyperdiploidy - B-ALL with Hypodiploidy - B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3 - B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1 - B-ALL, BCR-ABL1-Like - B-ALL with iAMP21 - B-ALL, Not Otherwise Specified
- HAEM5:Early T-precursor lymphoblastic leukaemia / lymphoma - HAEM4:NK-Lymphoblastic Leukemia/Lymphoma
Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) (Overview Page Link)
- HAEM5:Monoclonal B-cell lymphocytosis
- HAEM5:Splenic diffuse red pulp small B-cell lymphoma - HAEM5:Hairy cell leukaemia Variant
- HAEM5:Lymphoplasmacytic lymphoma
- HAEM5:Mu heavy chain disease - HAEM5:Gamma heavy chain disease - HAEM5:Alpha heavy chain disease
- HAEM5:Non-IgM monoclonal gammopathy of undetermined significance - HAEM5:Plasma cell myeloma / multiple myeloma - HAEM5:Plasma cell myeloma / multiple myeloma Variants - HAEM5:Plasmacytoma - HAEM4:Monoclonal Immunoglobulin Deposition Diseases - HAEM5:Immunoglobulin-related (AL) amyloidosis - HAEM5:Monoclonal immunoglobulin deposition disease - HAEM4:Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome - HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome - HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome
- HAEM5:Paediatric nodal marginal zone lymphoma
- HAEM5:Follicular lymphoma - HAEM5:In situ follicular B-cell neoplasm - HAEM5:Duodenal-type follicular lymphoma
- HAEM5:Leukaemic non-nodal mantle cell lymphoma - HAEM5:In situ mantle cell neoplasm
- HAEM5:Fibrin-associated large B-cell lymphoma
- HAEM5:KSHV/HHV8-associated multicentric Castleman disease - HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma - HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder
- HAEM4:High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements - HAEM4:High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)
Mature T- and NK-cell Neoplasms (Overview Page Link)
- HAEM5:Systemic EBV-positive T-cell lymphoma of childhood - HAEM5:Systemic chronic active EBV disease - HAEM5:Hydroa vacciniforme lymphoproliferative disorder - HAEM5:Severe mosquito bite allergy
- HAEM5:Enteropathy-associated T-cell lymphoma - HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma - HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) - HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract
- HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis - HAEM5:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma
- HAEM5:Primary cutaneous gamma/delta T-cell lymphoma - HAEM5:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma - HAEM5:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder - HAEM5:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder
- HAEM5:Nodal TFH cell lymphoma, angioimmunoblastic-type - HAEM5:Nodal TFH cell lymphoma, follicular-type - HAEM5:Nodal TFH cell lymphoma, NOS
Hodgkin Lymphomas (Overview Page Link)
- HAEM5:Classic Hodgkin lymphoma - HAEM5:Classic Hodgkin lymphoma - HAEM5:Classic Hodgkin lymphoma - HAEM5:Classic Hodgkin lymphoma
Immunodeficiency-Associated Lymphoproliferative Disorders (Overview Page Link)
- HAEM4:Non-Destructive Post-Transplant Lymphoproliferative Disorders - HAEM5:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation - HAEM4:Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) - HAEM4:Monomorphic B-cell PTLD - HAEM4:Monomorphic T/NK-cell PTLD - HAEM4:Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder
Histiocytic and Dendritic Cell Neoplasms (Overview Page Link)
- HAEM5:Langerhans cell histiocytosis - HAEM5:Langerhans cell sarcoma
- HAEM5:EBV-positive inflammatory follicular dendritic cell sarcoma
Notes
*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.